Fundraising Fox
🦊/People
Sign in

Dima Kuzmin

InvestorFounder

Managing Partner at 4BIO Capital · Board Director & Scientific Co-Founder at NV Therapeutics

London

Writes $100K – $5M checks · typically $1.5M

FoundedNV Therapeutics

Kauffman Fellow · Class 26

Find your path to Dima

847 people in our graph share verified history with Dima — schools, employers, funds. One of them is your warm intro.

Tobi CokerunlockedDima: together at Kauffman Fellows (2023–2025)
×10Dima: together at Kauffman Fellows
Dima: together at University of Oxford

About

Managing Partner at 4BIO Capital, holds a PhD.

Contact· self-published, not guessed

Board Director & Scientific Co-Founder at NV Therapeutics

Intro paths

→

In turn, Dima can intro founders to NV Therapeutics's investors below.

NV Therapeutics's investors · 1

4Bio VenturesLondon · since 2025

Co-founders at NV Therapeutics

JLJake Lamson
Jake LamsonCo-Founder & Director of Synthetic Biology
ATAdrian Thrasher
Adrian ThrasherScientific Co-Founder & Advisor
DK
Donald KohnScientific Co-Founder & Advisor
GSGiorgia Santilli
Giorgia SantilliScientific Co-Founder & Advisor

Experience

  1. 4BIO CapitalManaging Partnercurrent2014 — presentLondon Area, United Kingdom
  2. Yale UniversityAssistant Professor Adjunct of Medicinecurrent2021 — presentNew Haven, Connecticut, United States
  3. Kauffman FellowsKauffman Fellow - Graduatedcurrent2023 — presentSan Francisco Bay Area
  4. Kauffman FellowsKauffman Fellow - Class 262021 — 2023San Francisco Bay Area
  5. Cloverleaf BioBoard Membercurrent2026 — presentBoston, Massachusetts, United States
  6. NV TherapeuticsCo-founder and Chairman of the Boardcurrent2025 — presentSan Francisco Bay Area
  7. TrogenixCo-founder and Chairman of the Boardcurrent2023 — presentEdinburgh, Scotland, United Kingdom
  8. Ray Therapeutics, Inc.Board Membercurrent2021 — presentSan Diego, California, United States
  9. Hornet TherapeuticsChairman of the Boardcurrent2022 — presentBasel, Switzerland
  10. Code BiotherapeuticsBoard Observercurrent2025 — presentHatfield, Pennsylvania, United States
  11. Code BiotherapeuticsBoard Member2021 — 2025Hatfield, Pennsylvania, United States
  12. Araris Biotech AGChairman of the Board2024 — 2025Zurich, Switzerland
  13. Araris Biotech AGBoard Member2020 — 2024Zurich, Switzerland
  14. Redpin TherapeuticsBoard Member2020 — 2022New York, United States
  15. SparingVisionBoard Observer2020 — 2022Paris, Île-de-France, France
  16. UCLResearch Fellow2012 — 2017London Area, United Kingdom
  17. RetroSense TherapeuticsBoard Member2015Ann Arbor, Michigan
  18. Max Planck Institute for Brain Research, Frankfurt am MainDAAD Visiting Doctoral Fellow2008 — 2010Frankfurt Rhine-Main Metropolitan Area
  19. Max Planck Institute for Brain Research, Frankfurt am MainAlexander von Humboldt Foundation Visiting Graduate Scholar2007 — 2008
  20. N.N.Blokhin Russian Cancer Research CenterUndergraduate Research Assistant2001 — 2003

Skills & more

Biotechnology72Start-ups47Bioinformatics25R&D21Venture Capital21Strategy33Neuroscience12Technology Transfer12Science9Life Sciences9International Project Management8Entrepreneurship9
+8 moreLifesciencesDrug DiscoveryForesightMarket ResearchGovernment RelationsMarket AccessDue DiligenceCell Biology

Languages English · German

  • Fellow — Royal Society of Medicine
  • Fellow — Royal Society of Biology
  • RYA Coastal Skipper — Royal Yachting Association (RYA)

From Dima's professional profile.

Investments

Per curated public sources.

Colleagues at 4BIO Capital

Alexander Mckenna
Investment Associate at 4BIO Capital
Andrew Kozlov
Managing Partner at 4BIO Capital
Brian McVeigh
Venture Partner, USA at 4BIO Capital
Edward McGill
Financial Controller at 4BIO Capital
Eleanor Whate
Office Manager and Compliance Assistant at 4BIO Capital
Jack Shea-Firth
Investment Analyst at 4BIO Capital
Kieran Mudryy
Partner at 4BIO Capital
Natalie Johnston
Investment Principal at 4BIO Capital

Network4

Brian McVeighMentor
Venture Partner, USA at 4BIO Capital
Andrew Kozlov
Managing Partner at 4BIO Capital
Kieran Mudryy
Partner at 4BIO Capital
Natalie Johnston
Investment Principal at 4BIO Capital

Investors connected to Dima in public investor directories — a warm-intro map.

Frequently asked questions

Who is Dima Kuzmin?
Managing Partner at 4BIO Capital, holds a PhD.
Where does Dima Kuzmin work?
Dima Kuzmin is Board Director & Scientific Co-Founder of NV Therapeutics and Managing Partner at 4BIO Capital.
What check size does Dima Kuzmin write?
Dima Kuzmin typically writes checks of $100K – $5M.
What companies did Dima Kuzmin found?
Dima Kuzmin founded NV Therapeutics.
What companies has Dima Kuzmin invested in?
Investments tracked here include Araris Biotech, Code Biotherapeutics, Hornet Therapeutics, Orchard Therapeutics, Ray Therapeutics, Redpin Therapeutics.
Where did Dima Kuzmin go to school?
Dima Kuzmin studied at University of Oxford (MSc Experimental Therapeutics); Max Planck Society (DAAD Visiting Doctoral Fellow at the Max Planck Institute for Brain Research); Lomonosov Moscow State University (MSU) (PhD, Neurochemistry).

Founder mafias

4BIO Capital mafia2

Also came through, then founded or led a company.

Brian McVeighVenture PartnerFounded Code Biotherapeutics

Redpin Therapeutics mafia2

Also came through, then founded or led a company.

Brian McVeighExecutive ChairmanFounded Code Biotherapeutics

Same school

Shared employers